Barclays’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$25K Sell
2025
Q1
$66K Sell
2024
Q4
$228K Buy
2024
Q3
$233K Buy
2024
Q2
$127K Buy
2024
Q1
$153K Sell
2023
Q4
$121K Buy
2023
Q3
$135K Sell
2023
Q2
$184K Sell
2023
Q1
$215K Buy
2022
Q4
$47K Buy